Shucheng Hua Selected Research

Interferon Regulatory Factors

10/2019	The protective effect of interfering TLR9-IRF5 signaling pathway on the development of CVB3-induced myocarditis.
1/2019	A promising role of interferon regulatory factor 5 as an early warning biomarker for the development of human non-small cell lung cancer.
12/2018	Genetic variants of interferon regulatory factor 5 associated with the risk of community-acquired pneumonia.
5/2018	Expression Levels of Interferon Regulatory Factor 5 (IRF5) and Related Inflammatory Cytokines Associated with Severity, Prognosis, and Causative Pathogen in Patients with Community-Acquired Pneumonia.
5/2017	An AAAG-Rich Oligodeoxynucleotide Rescues Mice from Bacterial Septic Peritonitis by Interfering Interferon Regulatory Factor 5.
1/2017	An oligodeoxynucleotide with AAAG repeats significantly attenuates burn-induced systemic inflammatory responses via inhibiting interferon regulatory factor 5 pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shucheng Hua Research Topics

Disease

12	Neoplasms (Cancer) 01/2022 - 06/2010
9	Inflammation (Inflammations) 09/2021 - 04/2011
6	Asthma (Bronchial Asthma) 01/2022 - 04/2011
6	Lung Neoplasms (Lung Cancer) 01/2021 - 06/2010
5	Infections 12/2022 - 05/2018
4	Pneumonia (Pneumonitis) 12/2018 - 09/2010
2	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2022 - 01/2022
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 08/2021 - 01/2019
2	Carcinogenesis 08/2021 - 06/2015
2	Respiratory Hypersensitivity 04/2021 - 02/2012
2	Acute Lung Injury 01/2019 - 01/2017
2	Triple Negative Breast Neoplasms 01/2017 - 01/2016
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 05/2016 - 07/2015
2	Breast Neoplasms (Breast Cancer) 01/2016 - 06/2015
1	Ataxia Telangiectasia (Louis Bar Syndrome) 12/2022
1	Virus Diseases (Viral Diseases) 01/2022
1	Hyperplasia 04/2021
1	Respiratory Syncytial Virus Infections 10/2020
1	Adenocarcinoma of Lung 01/2020
1	Heart Injuries 10/2019
1	Myocarditis (Carditis) 10/2019
1	Communicable Diseases (Infectious Diseases) 12/2018
1	Autoimmune Diseases (Autoimmune Disease) 01/2018
1	Bites and Stings (Sting) 01/2018
1	Pleural Effusion (Pleural Effusions) 11/2017
1	Pleurisy (Pleuritis) 11/2017
1	Tuberculosis (Tuberculoses) 11/2017
1	Peritonitis 05/2017
1	Burns 01/2017
1	Lewis Lung Carcinoma 01/2016
1	Neoplasm Metastasis (Metastasis) 01/2016

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2016
6	Interferon Regulatory FactorsIBA 10/2019 - 01/2017
5	CytokinesIBA 12/2018 - 07/2014
4	DNA (Deoxyribonucleic Acid)IBA 12/2022 - 01/2018
4	Interleukin-6 (Interleukin 6)IBA 10/2019 - 01/2017
3	CateninsIBA 08/2021 - 06/2015
3	InterleukinsIBA 04/2021 - 07/2014
3	Pharmaceutical PreparationsIBA 01/2021 - 01/2016
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2019 - 01/2017
3	Transcription Factors (Transcription Factor)IBA 01/2019 - 05/2018
2	RNA (Ribonucleic Acid)IBA 01/2022 - 06/2015
2	Messenger RNA (mRNA)IBA 09/2021 - 05/2018
2	Interferon-gamma (Interferon, gamma)IBA 04/2021 - 05/2018
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021 - 01/2016
2	Interleukin-10 (Interleukin 10)IBA 12/2020 - 05/2018
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2019
2	MicroRNAs (MicroRNA)IBA 01/2018 - 01/2017
2	OligodeoxyribonucleotidesIBA 05/2017 - 01/2017
2	Epidermal Growth Factor (EGF)IBA 01/2017 - 01/2016
2	Small Interfering RNA (siRNA)IBA 06/2015 - 04/2011
2	Interleukin-23 (Interleukin 23)IBA 07/2014 - 04/2011
2	Interleukin-17 (Interleukin 17)IBA 07/2014 - 04/2011
2	OvalbuminIBA 02/2012 - 04/2011
1	Caffeine (No Doz)FDA LinkGeneric 12/2022
1	DNA-Activated Protein KinaseIBA 12/2022
1	AntioxidantsIBA 01/2022
1	LipidsIBA 01/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022
1	SuspensionsIBA 09/2021
1	MucinsIBA 09/2021
1	Sincalide FDA Link 08/2021
1	matrigelIBA 08/2021
1	Myosin-Light-Chain PhosphataseIBA 08/2021
1	GlucocorticoidsIBA 04/2021
1	zingeroneIBA 04/2021
1	AMP-Activated Protein KinasesIBA 04/2021
1	Interleukin-13IBA 04/2021
1	Interleukin-5 (Interleukin 5)IBA 04/2021
1	CamptothecinIBA 01/2021
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2021
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 10/2020
1	GTP Phosphohydrolases (GTPases)IBA 10/2020
1	GTP-Binding Proteins (G-Protein)IBA 10/2020
1	benzoylcarbonyl- aspartyl- glutamyl- valyl- aspartyl- fluoromethyl ketoneIBA 09/2020
1	Caspase 3 (Caspase-3)IBA 09/2020
1	Glycopyrrolate (Glycopyrronium Bromide)FDA LinkGeneric 04/2020
1	indacaterolIBA 04/2020
1	Fluticasone (Cutivate)FDA LinkGeneric 04/2020
1	Mometasone Furoate (Nasonex)FDA LinkGeneric 04/2020
1	Salmeterol Xinafoate (Serevent)FDA Link 04/2020
1	ErbB Receptors (EGF Receptor)IBA 01/2020
1	Toll-Like Receptor 9IBA 10/2019
1	Interferon Regulatory Factor-7 (Interferon Regulatory Factor 7)IBA 01/2019
1	Interferon Type IIBA 05/2018
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018
1	NF-kappa B (NF-kB)IBA 01/2018
1	Janus KinasesIBA 01/2018
1	Interleukin-2 (IL2)IBA 01/2018
1	Monoclonal AntibodiesIBA 01/2018
1	Cyclic AMP Response Element-Binding Protein (Cyclic AMP-Responsive DNA-Binding Protein)IBA 01/2018
1	Anti-Bacterial Agents (Antibiotics)IBA 11/2017
1	Coffee FDA Link 05/2016
1	CurcuminIBA 01/2016
1	MicellesIBA 01/2016
1	Cadherins (E-Cadherin)IBA 01/2016
1	C-Reactive ProteinIBA 11/2015
1	Indicators and Reagents (Reagents)IBA 11/2015

Therapy/Procedure

6	Therapeutics 01/2022 - 09/2010
1	Radiotherapy 01/2022